2019’s ACT meeting in Phoenix, AZ was the 40th Annual Meeting and brought some key highlights to the Lovelace Biomedical team. In addition to catching up with colleagues, scientists and business development team members had the opportunity to attend continuing education courses and scientific sessions in toxicology. In reviewing highlights with the scientific staff, several […]
Thinking about Scientific and professional development. As I reflect upon 2019 and the different trade shows I attended over 2019, it was an interesting year, with one show standing out for something other than scientific content. As the pharmaceutical industry has shifted over the last 10 years with travel budgets severely restricted since 2008, most […]
Highlighting our excellent staff at Lovelace Biomedical Today’s staff spotlight belongs to Janet Benson. Janet is one of Lovelace’s longest tenured scientist, with decades of experience and also one of the most respected and well-known leaders in the gene therapy space. Here, Janet gives us a little glimpse into her career, inspiration, and interests. […]
It was reinvigorating to get out from behind the desk, and out of the lab this past weekend to attend the 2019 NACFC in Nashville. First, a couple of admissions – I was only able to attend the last day and a half of the meeting, and this was my first time attending this one […]
Traumatic Brain Injury (TBI) is just one of the many areas of scientific study Lovelace Biomedical, along with its sister company the Mind Research Network (MRN), has in its repertoire. Dr. Andy Mayer, Professor of Translational Neuroscience at MRN is studying mild TBI, with the goal of improving diagnosis and treatment of cognitive deficits following […]
Highlighting our excellent staff at Lovelace Biomedical Today, we put the spotlight on Adam Werts. Adam recently joined Lovelace Biomedical as part of our veterinary research team. Adam gives us an insight to his life, his career, and what he’s up to since joining Lovelace Biomedical. Bio: I spent the first twenty-two years of my […]
Jacob McDonald, CSO – Lovelace Biomedical I set a disclaimer right away, in that I have been called a jack of all trades, and lately, a master of probably none (don’t tell my kids). I have been pontificating over the past couple of years on the quandary of quantitative PCR for support of Gene Therapy […]
– Jacob McDonald, CSO – Lovelace Biomedical Last summer, I wrote a business plan for Lovelace Biomedical. It aimed at continuing to focus our energy on expanding our preclinical services business. Recently, I was looking to update the business plan and was taken aback at just how much I had to revisit the story about […]
As someone who has watched the ASGCT conference grow fairly steadily over the last 11 years, the growth in meeting attendance and vendor presence between 2018 and 2019 is nothing short of stunning. It was not uncommon in the past few years to need to stand during sessions to hear presentations, but never before has there […]
Novel bioanalytical approaches to drug development – 5-AZA a case study to be presented at the 67th ASMS Conference in Atlanta Within drug development, the quantitation of drug levels within the systemic circulation and target tissues can provide insight into tolerance and / or efficacy. For small molecules the mainstay for quantitative analysis is LC-MS/MS. […]
